Company page

Editas Medicine, Inc.

Editas Medicine, Inc. is a public biotechnology company based in America, focused on developing transformative genomic medicines. The company's market capitalization is approximately $399 million. Editas is engaged in advancing its proprietary gene-editing technology to address various genetic diseases.